| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.77B | 35.84B | 39.34B | 33.51B | 36.80B | 29.55B |
| Gross Profit | 8.59B | 8.11B | 8.99B | 8.01B | 8.46B | 5.97B |
| EBITDA | 7.47B | 7.19B | 6.81B | 5.79B | 6.72B | 4.39B |
| Net Income | 3.65B | 3.93B | 3.57B | 3.05B | 5.86B | 2.13B |
Balance Sheet | ||||||
| Total Assets | 209.69B | 219.59B | 201.93B | 193.40B | 175.51B | 169.42B |
| Cash, Cash Equivalents and Short-Term Investments | 5.57B | 6.33B | 4.91B | 5.09B | 6.09B | 4.95B |
| Total Debt | 147.10B | 153.81B | 140.30B | 135.83B | 119.96B | 120.99B |
| Total Liabilities | 166.67B | 174.09B | 159.31B | 153.25B | 137.63B | 135.95B |
| Stockholders Equity | 42.87B | 45.34B | 42.49B | 39.79B | 37.56B | 33.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -7.82B | -3.33B | -14.93B | -1.41B | -19.89B |
| Operating Cash Flow | 0.00 | -7.77B | -3.25B | -14.87B | -1.30B | -19.88B |
| Investing Cash Flow | 0.00 | -2.89B | -68.00M | -903.00M | 3.62B | -81.00M |
| Financing Cash Flow | 0.00 | 12.06B | 3.14B | 14.73B | -1.16B | 20.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥107.82B | 9.51 | ― | 2.85% | 1.06% | -7.68% | |
72 Outperform | ¥49.52B | 8.08 | ― | 3.57% | 4.73% | 15.55% | |
65 Neutral | ¥1.19T | 8.84 | ― | 3.37% | 6.51% | 30.56% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥33.55B | 7.83 | ― | 4.66% | -8.90% | 9.92% | |
57 Neutral | ¥36.33B | 9.56 | ― | 3.90% | 53.30% | 35.91% | |
51 Neutral | ¥396.28B | 17.81 | ― | 3.62% | 16.26% | -52.33% |